Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-99,613
Closed -$4.58M 232
2022
Q3
$4.58M Buy
99,613
+67,513
+210% +$3.22M 0.05% 326
2022
Q2
$1.42M Buy
+32,100
New +$1.65M 0.01% 721
2017
Q2
Sell
-82,435
Closed -$4.83M 454
2017
Q1
$4.83M Sell
82,435
-40,606
-33% -$2.43M 0.08% 219
2016
Q4
$7.22M Buy
123,041
+7,657
+7% +$436K 0.14% 178
2016
Q3
$6.04M Buy
+115,384
New +$5.18M 0.09% 188
2016
Q1
Sell
-57,875
Closed -$1.33M 509
2015
Q4
$1.47M Buy
+57,875
New +$2.12M 0.02% 280
2015
Q3
Sell
-170,000
Closed -$9.37M 670
2015
Q2
$9.37M Buy
+170,000
New +$10.8M 0.16% 155

Other funds holding OVV

UBS O'Connor's OVV Position: Q4 2022 in Review

UBS O'Connor sold out of Ovintiv (OVV) in Q4 2022, closing a stake of 99,613 shares — an estimated $4.58M sold.

UBS O'Connor first reported a position in OVV in Q2 2015 and held it in 7 quarters. The position peaked at $9.37M in Q2 2015. 502 funds tracked by Wall St. Rank hold OVV as of Q4 2022.

  • UBS O'Connor reported no remaining Ovintiv position as of Q4 2022 after selling out during the quarter.
  • UBS O'Connor sold 99,613 Ovintiv shares in Q4 2022, an estimated $4.58M.
  • UBS O'Connor first reported a position in Ovintiv in Q2 2015 and held it in 7 quarters.
  • UBS O'Connor's Ovintiv position peaked at $9.37M in Q2 2015.
  • 502 funds tracked by Wall St. Rank held Ovintiv as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.